FOX 66 News at Ten
Story by Marilynn Marchione / ASSOCIATED PRESS
suggests that a shot every one to three months may someday give an
alternative to the daily pills that some people take now to cut their
risk of getting HIV.
The experimental drug has only been tested
for prevention in monkeys, but it completely protected them from
infection in two studies reported at an AIDS conference on Tuesday.
is the most exciting innovation in the field of HIV prevention that
I've heard recently," said Dr. Robert Grant, an AIDS expert at the
Gladstone Institutes, a foundation affiliated with the University of
California, San Francisco.
"Both groups are showing 100 percent
protection" with the drug, Grant said of the two groups of researchers.
"If it works and proves to be safe, it would allow for HIV to be
prevented with periodic injections, perhaps every three months."
a vaccine is developed, condoms are the best way to prevent infection
with the AIDS virus and many other sexually spread diseases. But not
everyone uses them, or does so all the time, so public health officials
have pursued other prevention options.
A drug used to treat
people with HIV — Gilead Science's Truvada — also is used to help
prevent infection in people who don't have the virus. A big study in gay
men a few years ago found it could cut this risk by up to 90 percent,
depending on how faithfully people take the daily pills.
research tested something that could make this type of prevention much
more practical — a long-acting experimental drug made by GlaxoSmithKline
PLC. The studies tested it in macaques exposed to a human-monkey
version of HIV.
Researchers at the Centers for Disease Control
and Prevention gave six monkeys shots of the drug every four weeks; six
others got dummy shots. All were exposed to the virus twice a week for
The monkeys who got the fake treatment were readily
infected "but the animals that received the long-acting drug remained
protected," said study leader Gerardo Garcia-Lerma of the CDC.
results mirror what was seen in the CDC's early research in monkeys on
Truvada, the pill that's available for HIV prevention now.
second study, Chasity Andrews and others at the Aaron Diamond AIDS
Research Center at Rockefeller University in New York gave eight monkeys
two shots of the drug, four weeks apart, and dummy shots to eight
others. The animals were exposed to the virus weekly for eight weeks.
Again, all animals given the fake treatment were quickly infected and
those on the drug were all protected.
To see how long a single
shot would last, they did a second study. The single shot protected 12
monkeys for about 10 weeks on average.
The dose used in a single shot corresponded to what people would get from a shot every three months, researchers said.
is really promising," said Dr. Judith Currier, an infectious disease
specialist at the University of California, Los Angeles. The research
"supports moving this forward" into human testing, she said.
is on the program committee for the meeting in Boston where the studies
were presented — the Conference on Retroviruses and Opportunistic
Infections. The New York study also was published online by the journal
Grant said the long-acting drug is chemically similar to
certain AIDS medicines sold now that are "extremely safe, well
tolerated and extremely potent." A mid-stage trial testing the
long-acting shots in people as a treatment, not a prevention, is already
underway, he said.
Wednesday, March 5 2014, 09:18 AM EST
National News Headlines
|Minneapolis-St. Paul Airport ticketing area temporarily evacuated after bag tests positive for explosives|
|Minneapolis-St. Paul International Airport reopened Saturday after part of the airport had to be evacuated when an unattended bag tested positive for an explosive.|
|Family attorney disputes police chief's account that officer fatally shot teen in self-defense|
|A South Carolina police chief says he will not release the name of an officer who fatally shot a 19-year-old man in a Hardee's parking lot, insisting the officer acted in self-defense.|
|Atlanta airport leads nation in number of guns found in carry-on bags at security checkpoints|
|Authorities say Atlanta's airport once again leads the nation in the number of guns found in carry-on bags.|
|How This Startup Is Helping Restaurants Be More Efficient About Delivery|
|DoorDash's web software and app offers restaurants on-demand delivery options using a team of Uber-style drivers.|
|Authorities: Man becomes unresponsive, dies after dashing into Dallas County jail lobby|
|Authorities say a panic-stricken man who dashed into a Dallas County jail lobby shouting that his wife was chasing him to kill him has died after being handcuffed and losing consciousness.|
|Firefighter battling California wildfires killed after being trapped in wind-fueled blaze|
|A firefighter killed by a wildfire in Northern California was exploring for ways to attack it when he became trapped after erratic winds stoked the blaze.|
|Short on Time and Money? You Can Still Develop a Strong Brand.|
|Get started by asking yourself these six questions.|
|Seattle CEO who set firm's minimum wage to $70G says he has hit hard times|
|The Seattle CEO who reaped a publicity bonanza when he boosted the salaries of his employees to a minimum of $70,000 a year has fallen on hard times following the decision.|
|Spike in suicides prompts additional oversight of Southern California women's prison|
|A spike in suicides and attempted suicides is prompting corrections officials to step up oversight at a women's prison as inspectors try to pinpoint what is causing women to kill themselves at such a startling rate.|
|Man admits beating friend to death with metal dumbbell, now faces up to 15 years in prison|
|A northern New Jersey man has pleaded guilty to aggravated manslaughter for beating his friend to death with a metal dumbbell.|